ABSTRACT
As the rates of various cardiometabolic risk factors rise, new treatments for such diseases and conditions continue to proliferate. While the development of therapeutic agents to combat risk factors, such as obesity and diabetes, still lags behind the epidemic, there are a variety of current therapies, both pharmacological and other, to arm the clinician in the battle to reduce cardiometabolic risk. While a full review of all the available treatments for cardiometabolic risk is beyond the scope of this chapter and, indeed, this volume, what follows is a brief summary of major treatment modalities.
